Nuclidium AGBasel-based NUCLIDIUM AG has successfully closed a Series B financing round of CHF 79 million (EUR 84 million) to advance the development of its copper-based radiopharmaceutical platform. The round was led by Kurma Growth Opportunities Fund, Angelini Ventures, Wellington Partners, and Neva SGR, a company of the Intesa Sanpaolo Group.
Tag Archive for: Munich
At the IZB, we are right in the middle of it allas one of the leading cell culture specialists in the heart of Germany’s biotech hotspot and as a medium manufacturer in life science research.
The extension, which was celebrated with an official groundbreaking ceremony, will connect the IZB campus in Martinsried to the Munich subway system.